Skip to content

The "inflammatory-brain network model" of late life depression based on TCM syndrome diagnosis and its predictive value of curative effect

The "inflammatory-brain network model" of late life depression based on TCM syndrome diagnosis and its predictive value of curative effect

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001608
Enrollment
Unknown
Registered
2025-08-26
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Late Life Depression

Interventions

Late Life Depression:Routine antidepressant treatment in clinical practice

Sponsors

Shandong Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients with Late Life Depression: Enrollment Criteria: Age=60 years; Han nationality male or female right-handed. Meets International Classification of Diseases (ICD) 10th edition At least one depressive episode at age 60 and later. Currently in a depressive episode (Hamilton Depression Rating Scale [17 items] score >17). No systemic antidepressant therapy in the 2 weeks prior to enrollment and no Modified Electra convulsive therapy (MECT) therapy in the past 3 months. Normal control: Enrollment Criteria: Age=60 years; No current or previous history of psychiatric illness.

Exclusion criteria

Exclusion criteria: Patients with Late Life Depression: Exclusion Criteria: Depression secondary to organic lesions or other psychiatric disorders; Those who are unable to cooperate such as serious violent attacks or suicidal behavior; Patients with mental retardation dementia epilepsy and end-stage disease. Normal control: Exclusion Criteria: Severe medical illness somatic illness.

Design outcomes

Primary

MeasureTime frame
The score reduction rate of the Hamilton Depression Rating Scale;The patient's remission status;

Secondary

MeasureTime frame
Cognitive function;Markers of inflammation;Indicators of brain function;Quality of life;Drug side effects;

Countries

China

Contacts

Public ContactMiao Qi

Shandong Mental Health Center

miaoqi90@126.com18811771819

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026